- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Production to be Fast Tracked In New York with Acquisition of Lithium-Ion Battery Plant Assets
Magnis Resources (ASX:MNS) is pleased to announce that Imperium3 New York (IM3NY) placed the winning bid for the acquisition of near new Lithium-ion battery manufacturing equipment currently located in North Carolina, USA.
Magnis Resources (ASX:MNS) is pleased to announce that Imperium3 New York (IM3NY) placed the winning bid for the acquisition of near new Lithium-ion battery manufacturing equipment currently located in North Carolina, USA. Magnis has completed a successful A$5.0 million capital raising to fund its share of the purchase and to increase its stake in IM3NY to a percentage level that will be disclosed on the closing of the purchase.
Lithium-ion Battery Plant Assets
The Lithium-ion battery plant assets consists of high quality new and near new equipment from major United States and European suppliers. Over US$200M was initially invested by the previous owners into the plant which was constructed and commenced full scale operations in 2016 and employed over 290 people. The liquidation sale of the equipment occurred as the previous manufacturers constrained production to bespoke lithium-ion batteries that had limited commercial appeal, while the facility itself was equipped to manufacture large volume batteries for the auto industry or power walls for home usage which are now growing in demand. The IM3NY team thoroughly reviewed the technology and confirmed the procured plant can easily and cost effectively be calibrated for such large volume manufacturing runs. As a result, the Imperium3 consortium is of the firm view that this is a low risk, cost-effective and value-accretive transaction.
The plant is currently housed in a facility in North Carolina and includes all operations from slurry making to coating to cell assembly, formation and testing and even includes module assembly and packing. The equipment will now be disconnected and packed for transport to Huron Campus in New York where it will be reassembled and re-engineered for battery production at a nominal 1GWh scale.
Plant re-engineering will be directed at incorporating Imperium3’s leading materials and IP processing technologies as well as introducing additional cylindrical battery production beyond that existing for prismatic.
As previously announced on 22 September 2017, Stage 1 development for 3GWh of production at Huron Campus had an original CAPEX cost of US$130m. This current equipment acquisition now allows IM3NY to produce over 1GWh at a significantly reduced CAPEX cost of US$5M plus removal, re-engineering and reassembly.
Details of the Acquisition
The purchase price of the plant equipment, raw materials and machinery is US$5 Million with a US$1 Million deposit accepted and close of purchase scheduled for completion in late February. The purchase was made through the Imperium3 NY consortium, in which Magnis and fellow partner C4V will equally co-invest to enable the purchase of the plant. This investment will result in an increased stake for Magnis in the Imperium3 NY consortium. Figures 1-3 are examples of the plant machinery acquired.
- Qualification of its performance leading, low cost and sustainable materials technologies;
- Demonstration of its supply chain viability;
- Acceleration of strategic partnering with major corporations in Lithium-ion Battery production;
- Validation of high yield battery production; and
- Acceleration of marketing and qualification of battery product to major Original Equipment Manufacturer
Capital Raising
The Company has raised A$5.0 million via a placement lead managed by Bell Potter Securities Limited to Institutional and sophisticated investors locally. The placement consisted of 12,500,000 shares in MNS at A$0.40 per share.
Magnis’ Chairman Frank Poullas added: “This transaction is an incredible opportunity for Magnis and its IM3NY partners to purchase high quality near new battery plant assets for such a small outlay. In comparison to the build cost of the original plant as well as a new plant of equivalent size, the value we have gained here is most satisfying. The battery plant equipment will allow us to get 1GWh of production in a short period of time. The demand for the placement in difficult market conditions shows the support for our acquisition.”
Frank Poullas
Chairman
Magnis Resources Limited
Ph: +61 2 8397 9888
www.magnis.com.au
Click here to connect with Magnis Resources (ASX:MNS) and receive an Investors Presentation
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.